Last reviewed · How we verify

NCT06040216

Evolution of EIFL Following PPV

Completed Last updated 15 September 2023
What this trial tests

trial testing optical coherence tomography in Epiretinal Membrane in 80 participants. Completed in 17 March 2020.

Timeline
15 January 2020
Primary endpoint
17 March 2020
17 March 2020

Quick facts

Lead sponsorKocaeli University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date15 January 2020
Primary completion17 March 2020
Estimated completion17 March 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli University

Who can join

18 and older, any sex, with Epiretinal Membrane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Various classification systems have been described for epiretinal membrane (ERM). One of them is a new OCT-based staging scheme based on displacement and reorganization of inner retinal layers called ectopic inner retinal layers (EIFL). We evaluated pre-and perioperative factors related to time for evolution of EIFL.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of optical coherence tomography

Trials testing the same drug.

Other recruiting trials for Epiretinal Membrane

Currently open trials in the same condition.

Other Kocaeli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06040216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing